These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31743052)

  • 1. Treatment of Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A Retrospective Chart Review.
    Stiefel HC; Kopplin LJ; Albini T; Chang M; Vegunta S; Suhler EB
    Ocul Immunol Inflamm; 2021 Apr; 29(3):566-571. PubMed ID: 31743052
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Interferon Alpha 2A and Pegylated Interferon Alpha 2A in Inflammatory Macular Edema.
    Couret C; Servant M; Lebranchu P; Hamidou M; Weber M
    Ocul Immunol Inflamm; 2020; 28(2):329-336. PubMed ID: 31821064
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study.
    Deuter CM; Koetter I; Guenaydin I; Stuebiger N; Zierhut M
    Retina; 2006 Sep; 26(7):786-91. PubMed ID: 16963852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interferon α2a in cystoid macular edema due to intraocular infection.
    Qian Z; Fardeau C; Cardoso JN; Jellab B; Fan X; LeHoang P
    Eur J Ophthalmol; 2015; 25(5):431-6. PubMed ID: 25790810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha 2b in the treatment of uveitic cystoid macular edema.
    Butler NJ; Suhler EB; Rosenbaum JT
    Ocul Immunol Inflamm; 2012 Apr; 20(2):86-90. PubMed ID: 22409560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon Alpha for the Treatment of Cystoid Macular Edema Associated with Presumed Ocular Tuberculosis.
    Oray M; Onal S; Uludag G; Akbay AK; Tugal-Tutkun I
    J Ocul Pharmacol Ther; 2017 May; 33(4):304-312. PubMed ID: 28414561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
    Manns M; Marcellin P; Poordad F; de Araujo ES; Buti M; Horsmans Y; Janczewska E; Villamil F; Scott J; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
    Lancet; 2014 Aug; 384(9941):414-26. PubMed ID: 24907224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.
    Rosen I; Kori M; Eshach Adiv O; Yerushalmi B; Zion N; Shaoul R
    World J Gastroenterol; 2013 Feb; 19(7):1098-103. PubMed ID: 23467199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.
    Ma P; Yang JM; Hou W; Song SD; Wang L; Lu W
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):601-5. PubMed ID: 23263720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis.
    Deuter CM; Kötter I; Günaydin I; Stübiger N; Doycheva DG; Zierhut M
    Br J Ophthalmol; 2009 Jul; 93(7):906-13. PubMed ID: 19321469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-efficacy analysis of peginterferon alfa-2b plus ribavirin compared with peginterferon alfa-2a plus ribavirin for the treatment of chronic hepatitis C.
    Malone DC; Tran TT; Poordad FF
    J Manag Care Pharm; 2005 Oct; 11(8):687-94. PubMed ID: 16194133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function Relationships in Uveitic Cystoid Macular Edema: Using En Face Optical Coherence Tomography to Predict Vision.
    Cohen LM; Goldstein DA; Fawzi AA
    Ocul Immunol Inflamm; 2016 Jun; 24(3):274-81. PubMed ID: 26471011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.
    Arevalo JF; Maia M; Garcia-Amaris RA; Roca JA; Sanchez JG; Berrocal MH; Wu L;
    Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
    Jacobson IM; Dore GJ; Foster GR; Fried MW; Radu M; Rafalsky VV; Moroz L; Craxi A; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Scott J; Sinha R; Beumont-Mauviel M
    Lancet; 2014 Aug; 384(9941):403-13. PubMed ID: 24907225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon Alpha-2a for the Treatment of Cystoid Macular Edema Secondary to Acute Retinal Necrosis.
    Aksu-Ceylan N; Cebeci Z; Altinkurt E; Kir N; Oray M; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2022; 30(7-8):1788-1797. PubMed ID: 34348058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b.
    Scotto G; Fazio V; Fornabaio C; Tartaglia A; Di Tullio R; Saracino A; Angarano G
    Drugs; 2008; 68(6):791-801. PubMed ID: 18416586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of efficacy of pegylated interferon alfa-2a or interferon alfa-2b combination therapy with nucleus(t)ide analogues in HBeAg positive chronic hepatitis B patients].
    Wang SQ; Xu KJ; Wu JZ; Liu XS; Luo TT; Yang RG; Geng XX; Huang RG; Lin JM; Jiang N
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):785-6. PubMed ID: 22423366
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.